LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Handheld Blood Gas Electrolyte Analyzer Advances Point-of-Care Testing (POCT)

By LabMedica International staff writers
Posted on 04 Jul 2023
Image: The i-Check handheld blood gas electrolyte analyzer (Photo courtesy of B&E)
Image: The i-Check handheld blood gas electrolyte analyzer (Photo courtesy of B&E)

A vital factor for patients in emergency and critical care settings is their rapidly changing physiological state, which can deteriorate quickly and necessitate immediate diagnosis and clinical decisions for improving patient outcomes. Point-of-care testing (POCT) is a significant advancement in critical care settings, designed to provide decentralized, patient-centered healthcare. Quick access to blood measurements, especially blood gases, and electrolytes, can lead to better clinical outcomes. Now, a new handheld blood gas electrolyte analyzer designed to meet the urgency of clinical decision provides prompt POCT and improves patient outcomes while reducing therapeutic turnaround time (TTAT) and shortening door-to-clinical-decision time.

The newly-launched i-Check handheld blood gas electrolyte analyzer from B&E Biotechnology Co. Ltd. (Yantai, China) adopts microfluidic and electrochemical detection technology. Its single-use cartridge includes a plastic substrate, a multi-biosensor array, a calibrator pouch, a sample injection port, and a waste chamber. Notably, the multi-biosensor array is produced by silk-screen printing. The printing ink materials used comprise only carbon, silver, and insulation, without any noble metal, which significantly lowers the production cost compared to other manufacturers. Furthermore, special production technology enables its long-term stability to last 12 months under refrigeration. The i-Check handheld blood gas electrolyte analyzer requires only 95 μL of blood to measure pH, PCO2, PO2, K, Na, iCa, Hct, etc. in just one minute.

Among other benefits, the cartridge can be used immediately after removal from the refrigerator and does not need to be brought up to room temperature due to the efficient heating effect of the attached carbon heating film. It can rapidly increase the temperature of the electrode and flow path and maintain them at 37℃ when paired with an IR temperature sensor. Each cartridge has its own standard solution (calibrator), facilitating a one-point calibration, and eliminating the need for an additional reagent package. Calibration before sample injection is performed to prevent the impact of blood cell precipitation on Hct testing. Each cartridge also contains a unique RFID chip for quality control, effectively avoiding erroneous results from using expired cartridges. In a correlation experiment with a desktop blood gas analyzer, the i-Check excelled in test performance with correlation coefficients R2 all above 0.973 (n=76).

Related Links:
B&E Biotechnology Co. Ltd. 

Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more